Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$22.09M$22.09Mderived+14.4% vs Q4 2022 Net Income-$1.51M-$1.51MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$2,870,000+22.6% Operating Incomederived-$547,000N/M Operating Cash Flowderived-$43,000N/M Free Cash Flowderived-$86,000— Margins · derivedGross margin13.0%+0.9 pt vs Q4 2022
Operating margin-2.5%+7.7 pt vs Q4 2022
Net margin-6.8%+5.4 pt vs Q4 2022
ended Dec 31, 2023 · filed Mar 21, 2024 · 81 d after period end